Among other aspects, provided herein are multi-arm polymeric prodrug conjugates of taxane-based compounds and/or fluorinated forms thereof. Methods of preparing such conjugates as well as methods of administering the conjugates are also provided. Upon administration to a patient, release of the taxane-based compound is achieved.

This invention is in the field of medicinal chemistry. The present invention provides cell-laden hydrogels and hydrogel assemblies thereof for use in tissue engineering. The present invention provides methods of producing various hydrogels and hydrogel assemblies and pharmaceutical compositions thereof. The present invention provides for a microgel comprising an encapsulated population of live primary human cells in a hydrogel comprising a polymeric network.

To provide a fluorinated ether compound, a fluorinated ether composition and a coating liquid that are able to form a surface layer which is excellent in water/oil repellency, abrasion resistance, fingerprint stain removability, lubricity and outer appearance, and an article having such a surface layer. A fluorinated ether compound represented by A.sup.1-O(R.sup.f1O).sub.m1Q.sup.1-[C(O)N(R.sup.1)].sub.p1R.sup.11C[R.sup.12SiR.sup.13.sub.n1X.sup.1.sub.3-n1].sub.3, wherein A.sup.1 is a C.sub.1-20 perfluoroalkyl group; R.sup.f1 is a fluoroalkylene group having no branched structure; m1 is an integer from 2 to 210; Q.sup.1 is a single bond or a fluoroalkylene group having no branched structure; R.sup.1 is a hydrogen atom, etc.; p1 is 0 or 1; R.sup.11 is a single bond, an alkylene group, etc.; R.sup.12 is an alkylene group, etc.; R.sup.13 is a monovalent hydrocarbon group, etc.; X.sup.1 is a hydrolyzable group; and n1 is an integer of from 0 to 2.

To provide a fluorinated ether compound, a fluorinated ether composition and a coating liquid that are able to form a surface layer which is excellent in water/oil repellency, abrasion resistance, fingerprint stain removability, lubricity and outer appearance, and an article having such a surface layer. A fluorinated ether compound represented by A.sup.1-O(R.sup.f1O).sub.m1Q.sup.1-[C(O)N(R.sup.1)].sub.p1R.sup.11C[R.sup.12SiR.sup.13.sub.n1X.sup.1.sub.3-n1].sub.3, wherein A.sup.1 is a C.sub.1-20 perfluoroalkyl group; R.sup.f1 is a fluoroalkylene group having no branched structure; m1 is an integer from 2 to 210; Q.sup.1 is a single bond or a fluoroalkylene group having no branched structure; R.sup.1 is a hydrogen atom, etc.; p1 is 0 or 1; R.sup.11 is a single bond, an alkylene group, etc.; R.sup.12 is an alkylene group, etc.; R.sup.13 is a monovalent hydrocarbon group, etc.; X.sup.1 is a hydrolyzable group; and n1 is an integer of from 0 to 2.

The present invention provides, among other things, compounds that include a water-soluble and non-peptidic polymer as well as a maleimidyl group. The compounds are useful as, among other things, polymeric reagents.

The present invention provides, among other things, compounds that include a water-soluble and non-peptidic polymer as well as a maleimidyl group. The compounds are useful as, among other things, polymeric reagents.

The present invention provides, among other things, compounds that include a water-soluble and non-peptidic polymer as well as a maleimidyl group. The compounds are useful as, among other things, polymeric reagents.

Among other aspects, provided herein are multi-arm polymeric prodrug conjugates of taxane-based compounds and/or fluorinated forms thereof. Methods of preparing such conjugates as well as methods of administering the conjugates are also provided. Upon administration to a patient, release of the taxane-based compound is achieved.

Among other aspects, provided herein are multi-arm polymeric prodrug conjugates of taxane-based compounds and/or fluorinated forms thereof. Methods of preparing such conjugates as well as methods of administering the conjugates are also provided. Upon administration to a patient, release of the taxane-based compound is achieved.

The invention relates to a ligand compound having a structure A-B-C, wherein (a) A represents a mono- or polyphosphorylated amino acid linked to part B by its amino group to form an amide bond; B represents (i) a carboxylic acid, and (ii) an amino acid or peptidyl group of 2-10 amino acids, an alkyl or alkenyl group comprising 1-26 carbon atoms, a polyethylene glycol group comprising 1-26 carbon atoms or a combination thereof covalently linked to the carboxylic acid; and C represents a hydrophilic group covalently linked to the group of B (ii) or (b) A represents a mono-or polyphosphorylated amino acid linked to B by its carboxylic acid to form an amide bond; B represents an amino acid or peptidyl group of 2-10 amino acids, an amino substituted alkyl or alkenyl group comprising 1-26 carbon atoms, an amino substituted polyethylene glycol group comprising 1-26 carbon atoms or a combination thereof covalently linked to A by their amino group; C represents a hydrophilic group covalently linked to the group of B. The invention further relates to a coated metal nanoparticle such as super paramagnetic iron oxide nanoparticle (SPIONs) coated with a plurality of the aforementioned ligands and a method of producing thereof.